Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $986.48 MXN
Change Today +11.59 / 1.19%
Volume 608.0
TEVAN On Other Exchanges
Symbol
Exchange
Mexico
Tel Aviv
Frankfurt
As of 4:09 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for teva pharmaceutical-sp adr (TEVAN)

Although debt as a percent of total capital decreased at Teva Pharmaceutical Industries Limited over the last fiscal year to 30.66%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 96.74 days worth of sales outstanding. Last, inventory levels, relative to the Cost of Goods Sold, are typical for the industry but have shown a consistent increase during the last 4 years. This implies a potential loss of efficiency or pricing power.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents1,096.02,879.01,038.02,226.0
Short-Term Investments----28.073.0
Trading Asset Securities--4.02.0--
TOTAL CASH AND SHORT TERM INVESTMENTS1,096.02,883.01,068.02,299.0
Accounts Receivable6,213.05,572.05,338.05,408.0
TOTAL RECEIVABLES6,213.05,572.05,338.05,408.0
Inventory5,012.05,502.05,053.04,371.0
Deferred Tax Assets, Current966.01,142.01,084.0993.0
Other Current Assets1,166.01,256.01,177.01,325.0
TOTAL CURRENT ASSETS14,453.016,355.013,720.014,396.0
Gross Property Plant and Equipment7,802.08,412.09,024.09,309.0
Accumulated Depreciation-2,429.0-2,823.0-3,105.0-3,345.0
NET PROPERTY PLANT AND EQUIPMENT5,373.05,589.05,919.05,964.0
Goodwill18,293.018,856.018,981.018,408.0
Long-Term Investments653.0205.0179.0176.0
Deferred Tax Assets, Long Term62.0110.0606.0388.0
Other Intangibles10,316.07,745.06,476.05,512.0
Other Long-Term Assets992.01,749.01,627.01,576.0
TOTAL ASSETS50,142.050,609.047,508.046,420.0
    
LIABILITIES & EQUITY    
Accounts Payable3,572.03,376.03,317.03,171.0
Accrued Expenses--2,983.03,090.03,941.0
Short-Term Borrowings2,591.045.0458.046.0
Current Portion of Long-Term Debt/Capital Lease1,689.02,965.01,346.01,715.0
Other Current Liabilities, Total5,778.03,500.03,717.03,382.0
TOTAL CURRENT LIABILITIES13,676.012,888.011,965.012,289.0
Long-Term Debt10,236.011,712.010,387.08,566.0
Minority Interest148.099.071.042.0
Deferred Tax Liability Non-Current2,610.01,849.01,247.01,101.0
Other Non-Current Liabilities1,277.01,293.01,273.01,109.0
TOTAL LIABILITIES27,799.027,742.024,872.023,065.0
Common Stock50.050.050.050.0
Additional Paid in Capital13,374.013,474.013,628.014,121.0
Retained Earnings11,284.012,346.012,535.014,436.0
Treasury Stock-1,924.0-3,085.0-3,557.0-3,951.0
Comprehensive Income and Other-589.0-17.0-91.0-1,343.0
TOTAL COMMON EQUITY22,195.022,768.022,565.023,313.0
TOTAL EQUITY22,343.022,867.022,636.023,355.0
TOTAL LIABILITIES AND EQUITY50,142.050,609.047,508.046,420.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVAN:MM $986.48 MXN +11.59

TEVAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TEVAN.
View Industry Companies
 

Industry Analysis

TEVAN

Industry Average

Valuation TEVAN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.